OTCMKTS:IVITF

Invictus MD Strategies Stock Forecast, Price & News

$0.04

0.00 (0.00 %)

(As of 05/14/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.04

▼

$0.06

50-Day Range

$0.04

▼

$0.05

52-Week Range

$0.00

▼

$0.12

Volume28,819 shs

Average Volume119,436 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive IVITF News and Ratings via Email

Sign-up to receive the latest news and ratings for Invictus MD Strategies and its competitors with MarketBeat's FREE daily newsletter.

About Invictus MD Strategies

Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.

Cantor Fitzgerald Maintains Overweight on Trulieve Cannabis, Lowers Price Target to $76
May 12, 2021 | benzinga.com

Cannabis Stock Gainers And Losers From May 3, 2021
May 5, 2021 | msn.com

Invictus MD Strategies Corp. (OTCMKTS:IVITF) Short Interest Down 63.3% in April
April 29, 2021 | americanbankingnews.com

Invictus Announces Share Issuance
January 26, 2021 | finance.yahoo.com

Invictus MD Strategies Corp Class A (IVITF)
November 2, 2020 | nasdaq.com

Cannabis Brands Get Loud With Rock-Branded Weed Featuring Santana, Jerry Garcia
October 24, 2020 | msn.com

IIROC Trading Halt - GENE.WT
October 21, 2020 | markets.businessinsider.com

Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.
September 29, 2020 | bloomberg.com

Invictus Announces Signing of a Purchase Agreement
June 22, 2020 | finance.yahoo.com

BRIEF-Invictus MD Strategies Corp says Harbir Toor Has Ceased To Be Co's CFO, Effective Immediately
May 20, 2020 | www.reuters.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:IVITF

Previous Symbol

CUSIPN/A

CIKN/A

Webinvictus-md.com

Phone844-800-6086

EmployeesN/A

Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.56 out of 5 stars

Medical Sector

1458th out of 2,042 stocks

Drug Manufacturers - Specialty & Generic Industry

34th out of 61 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Invictus MD Strategies.

2.8 Community Rank

Outperform Votes
Invictus MD Strategies has received 18 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Invictus MD Strategies has received 14 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Invictus MD Strategies has received 56.25% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Invictus MD Strategies and other stocks. Vote “Outperform” if you believe IVITF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IVITF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Invictus MD Strategies does not currently pay a dividend.
Dividend Growth
Invictus MD Strategies does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Invictus MD Strategies insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Invictus MD Strategies (OTCMKTS:IVITF) Frequently Asked Questions

What stocks does MarketBeat like better than Invictus MD Strategies?

Wall Street analysts have given Invictus MD Strategies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Invictus MD Strategies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Invictus MD Strategies?

Invictus MD Strategies saw a decrease in short interest in April. As of April 15th, there was short interest totaling 1,800 shares, a decrease of 63.3% from the March 31st total of 4,900 shares. Based on an average daily trading volume, of 59,200 shares, the short-interest ratio is currently 0.0 days.
View Invictus MD Strategies' Short Interest.

How has Invictus MD Strategies' stock been impacted by COVID-19 (Coronavirus)?

Invictus MD Strategies' stock was trading at $0.03 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IVITF stock has increased by 40.0% and is now trading at $0.0420.
View which stocks have been most impacted by COVID-19.

Who are Invictus MD Strategies' key executives?

Invictus MD Strategies' management team includes the following people:

Mr. Daniel Stanislav Kriznic, Founder and Advisor to Chairman & CEO (Age 42, Pay $883.56k)
Mr. Aaron Bowden C.A., CPA, CPA, CA, Advisor
Imran Haider, Chief Exec. Officer
Ms. Elena Gershtein, Acting CFO & Controller
Mr. Marc Ripa, Chief Operating Officer
Ms. Brenda Mae Dixon, Chief Science Officer
Mr. Larry Heinzlmeir MBA, VP of Marketing & Communications
Mr. Gene Simmons, Chief Evangelist Officer (Age 71)

Who are some of Invictus MD Strategies' key competitors?

Some companies that are related to Invictus MD Strategies include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics (CP1).
View all of IVITF's competitors.

What is Invictus MD Strategies' stock symbol?

Invictus MD Strategies trades on the OTCMKTS under the ticker symbol "IVITF."

How do I buy shares of Invictus MD Strategies?

Shares of IVITF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invictus MD Strategies' stock price today?

One share of IVITF stock can currently be purchased for approximately $0.04.

What is Invictus MD Strategies' official website?

The official website for Invictus MD Strategies is invictus-md.com.

How can I contact Invictus MD Strategies?

The company can be reached via phone at 844-800-6086.

This page was last updated on 5/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Invictus MD Strategies Stock Forecast, Price & News

Adding

Adding

Adding Invictus MD Strategies Corp.

About Invictus MD Strategies

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

2.8 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment